The investigation determined an unexpected (b)(6) result was obtained from a single anti-hbs (b)(6) panel sample as part of internal post expiry stability testing, using a vitros 3600 immunodiagnostic system.A definitive assignable cause could not be determined.Precision testing was not performed to verify that the instrument was operating as expected, therefore atypical instrument performance cannot be ruled out as contributing to the event.Relevant quality control data was not available, therefore the performance of the vitros ahbs reagent could also not be evaluated and a reagent issue could not be ruled out as a contributing factor.
|